Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Appropriate BIS Range and Propofol Concentration During TIVA Combined With Midazolam, Dexmedetomidine or Esketamine
NCT07736352Recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Jul 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Randomised trial of midazolam, dexmedetomidine and esketamine (4 arms), sponsored by China-Japan Friendship Hospital. Primary endpoints: Bispectral Index value up to 30 minutes and Propofol Effect-Site Concentration up to 30 minutes. Started Jul 2026; status: recruiting.
02
Drugs
midazolamdexmedetomidineesketamine
Beyond the preview
Go deeper on NCT07736352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07736352.